Bevacizumab,Durvalumab,Olaparib,Carboplatin,Paclitaxel
AstraZeneca,roche,Merck
[]
i don't understand why two asco news outlets have different headlines for the same trial results. the first headline from asco daily news is wrong, the second from asco post is correct- the data were for pfs, not os. #asco23 
Personal account. Med Onc. Associate Prof. @queensoncology @QueensuPHS. #cancerpolicy #cancergroundshot. Pubs: https://t.co/FTRPKNykq3 Talks- https://t.co/anav3AIZjO